OptiNose Inc (DELISTED) (OPTN:DL)
9.60
0.00 (0.00%)
USD |
NASDAQ |
May 23, 16:00
OptiNose EPS Diluted (Quarterly) : -1.921 for March 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Akoya Biosciences Inc (DELISTED) | -0.3152 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Ionis Pharmaceuticals, Inc. | -0.805 |
| Cassava Sciences, Inc. | -0.2237 |
| Aptevo Therapeutics, Inc. | -40.13 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.42M |
| Revenue (Quarterly) | 18.51M |
| Total Expenses (Quarterly) | 40.93M |
| Enterprise Value | 151.50M |
| Gross Profit Margin (Quarterly) | 90.55% |
| Profit Margin (Quarterly) | -121.1% |
| Earnings Yield | -30.91% |
| Normalized Earnings Yield | -29.59 |